<sentence id="0">Inhibition of IL-17 production by signal transduction inhibitors and anti-rheumatic drugs</sentence>
<sentence id="1">Having observed the increased IL-17 production in RA PBMC , it was important to know which signal transduction pathways were involved .</sentence>
<sentence id="2">As illustrated in Fig .</sentence>
<sentence id="3">3 , an significant decrease in anti-CD3-induced IL-17 production was observed when co-incubated with NF-kappaB inhibitor , PDTC and dexamethasone in comparison with anti-CD3 alone ( 38 +/- 5 and 54 +/- 11 versus 98 +/- 19 pg/ml , respectively ; P < 0.05 ) .</sentence>
<sentence id="4">LY294002 and wortmannin , as an inhibitor of PI3K , also markedly inhibited the anti-CD3-induced IL-17 production in RA PBMC ( 98 +/- 19 versus 38 +/- 10 pg/ml [ P < 0.005 ] and 48 +/- 4 pg/ml [ P < 0.05 ] , respectively ) .</sentence>
<sentence id="5">The calcineurin inhibitors cyclosporin A and FK506 also downregulated the IL-17 secretion as well as the mitogen-activated protein kinase ( MAPK ) p38 inhibitor SB203580 did , whereas rapamycin and PD98059 had <scope type="neg" id="0"><cue type="neg" id="0">no</cue> effect</scope> on IL-17 levels ( Fig .</sentence>
<sentence id="6">3 ) .</sentence>
<sentence id="7">To evaluate the possibility of non-specific inhibition by the drug at high concentrations , we observed the dose response of PDTC and LY294002 for the inhibition of IL-17 production in PBMC .</sentence>
<sentence id="8">There were dose-dependent inhibitions of IL-17 production with chemical inhibitors ( Fig .</sentence>
<sentence id="9">4a ) .</sentence>
<sentence id="10">The other inhibitors in addition to PDTC and LY294002 showed the same pattern of inhibition .</sentence>
<sentence id="11"><scope type="neg" id="1">Cytotoxic effects on PBMC by the chemical inhibitors at experimental concentrations were <cue type="neg" id="1">not</cue> observed</scope> ( Fig .</sentence>
<sentence id="12">4b ) .</sentence>